Paul La Rosée Selected Research

Paul La Rosée Research Topics

Disease

21	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 04/2002
7	Neoplasms (Cancer) 01/2022 - 04/2002
7	Lymphoma (Lymphomas) 11/2020 - 01/2011
4	Hyperferritinemia 01/2021 - 01/2018
4	Leukemia 01/2020 - 11/2004
3	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2022 - 03/2016
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2021 - 10/2020
3	Critical Illness (Critically Ill) 01/2021 - 10/2019
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2014 - 11/2004
2	Macrophage Activation Syndrome 01/2022 - 03/2016
2	Philadelphia Chromosome 01/2020 - 04/2002
2	Sepsis (Septicemia) 01/2020 - 12/2019
2	Inflammation (Inflammations) 09/2017 - 09/2014
2	Infections 09/2017 - 04/2016
2	Bacteremia 04/2016 - 01/2016
2	Disease Progression 07/2014 - 09/2009
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2012 - 12/2004
1	Cognitive Dysfunction 01/2022
1	COVID-19 01/2021
1	Cytopenia 01/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 08/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Malaria 01/2020
1	Hepatitis 01/2020
1	Lymphopenia (Lymphocytopenia) 12/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2019
1	Aspergillosis 02/2017
1	Fever (Fevers) 04/2016
1	Febrile Neutropenia 04/2016
1	Intracranial Embolism 01/2016
1	Thrombosis (Thrombus) 01/2016
1	Cytokine Release Syndrome 01/2015
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2014
1	Bone Marrow Failure Disorders 09/2014
1	Pleural Effusion (Pleural Effusions) 10/2013
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 07/2013
1	Aplastic Anemia (Anemia, Hypoplastic) 06/2013
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 01/2012

Drug/Important Bio-Agent (IBA)

18	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 07/2002
8	Phosphotransferases (Kinase)IBA 01/2012 - 12/2002
6	Tyrosine Kinase InhibitorsIBA 01/2020 - 02/2008
5	nilotinib FDA Link 01/2020 - 05/2008
5	Dasatinib (BMS 354825)FDA Link 01/2020 - 03/2010
4	Rituximab (Mabthera)FDA Link 11/2020 - 11/2017
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 04/2002
3	BI 836826IBA 02/2021 - 10/2020
3	Ferritins (Ferritin)IBA 01/2021 - 01/2018
3	ruxolitinibIBA 01/2021 - 03/2016
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2020 - 08/2014
3	Biomarkers (Surrogate Marker)IBA 10/2019 - 05/2008
3	Tyrosine (L-Tyrosine)FDA Link 07/2014 - 11/2004
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022 - 01/2015
2	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 01/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020 - 04/2019
2	Prednisone (Sone)FDA LinkGeneric 11/2020 - 04/2019
2	Vincristine (Oncovin)FDA LinkGeneric 11/2020 - 04/2019
2	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2017 - 08/2014
2	Proteins (Proteins, Gene)FDA Link 04/2016 - 07/2014
2	Pharmaceutical PreparationsIBA 11/2011 - 11/2006
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2004 - 11/2004
2	Arsenic Trioxide (Trisenox)FDA Link 07/2002 - 04/2002
1	SteroidsIBA 01/2022
1	Interleukin-1 (Interleukin 1)IBA 01/2022
1	Transaminases (Aminotransferases)IBA 01/2021
1	Anaplastic Lymphoma KinaseIBA 08/2020
1	ponatinibIBA 01/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2018
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 11/2017
1	Methotrexate (Mexate)FDA LinkGeneric 11/2017
1	AntigensIBA 09/2017
1	AzolesIBA 02/2017
1	Sodium Glutamate (Accent)IBA 02/2017
1	Phosphatidylcholines (Phosphatidylcholine)IBA 04/2016
1	Peptides (Polypeptides)IBA 04/2016
1	ProteomeIBA 04/2016
1	Interleukin-6 (Interleukin 6)IBA 04/2016
1	ProcalcitoninIBA 04/2016
1	C-Reactive ProteinIBA 04/2016
1	amsonic acid (DAS)IBA 03/2016
1	Janus Kinase 1IBA 03/2016
1	Daptomycin FDA Link 01/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2015
1	Azacitidine (5 Azacytidine)FDA Link 09/2014
1	ofatumumab FDA Link 07/2013
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 06/2013

Therapy/Procedure

11	Therapeutics 01/2022 - 12/2002
2	Critical Care (Surgical Intensive Care) 01/2022 - 01/2020
2	Investigational Therapies (Experimental Therapy) 08/2020 - 01/2012
1	Salvage Therapy 01/2022
1	Renal Dialysis (Hemodialysis) 01/2021
1	Extracorporeal Membrane Oxygenation 01/2021
1	Homologous Transplantation 08/2020
1	Immunotherapy 12/2019
1	Radiotherapy 11/2017
1	Stem Cell Transplantation 11/2017
1	Drug Therapy (Chemotherapy) 09/2017
1	Hematopoietic Stem Cell Transplantation 09/2017
1	Induction Chemotherapy 08/2014
1	Drug Tapering 10/2013
1	Aftercare (After-Treatment) 07/2013